| Value | ₹250.0 Cr |
|---|
BSE filing, NSE: PARADEEP. Summary written from the filing by ALFA Finder's alert engine.
Paradeep Phosphates Ltd: key numbers
- Share price
- ₹129.10
- Market cap
- ₹13,407 Cr
- Revenue (annual)
- ₹21,826 Cr
- Net profit (annual)
- ₹996.4 Cr
- P/E (TTM)
- 15.8×Sector 18.4×
- Promoter holding
- 57.85%-0.01% QoQ
- FII holding
- 4.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Paradeep Phosphates Ltd
All →Paradeep Phosphates Results Update
Paradeep Phosphates reported Q2 FY27 revenue of ₹7,364 crore and PAT of ₹122 crore. H1 FY27 turnover reached ₹13,488 crore on 2 million tons sold.
Paradeep Phosphates Q2 FY27 Results: Net Profit ₹121 Cr, Down 64.6% YoY
Paradeep Phosphates Ltd reported revenue from operations of ₹7,364 Cr (+7.2% YoY) and net profit of ₹121 Cr (-64.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹121 Cr · -64.6% YoY
Paradeep Phosphates Board Meeting Date
Paradeep Phosphates informed exchanges that its Board is scheduled to meet on 29 Oct 2026 to consider unaudited Q1 and H1 results. The trading window remains closed till 31 Oct 2026.
Paradeep Phosphates Capacity Expansion: ₹4,750 Cr Investment
Paradeep Phosphates signed an MoU with Odisha Govt for ₹4,750 Cr investment in new chemical and fertilizer plants. The expansion adds a chemical plant and bio-fertilizers facility.
- Value
- ₹4,750 Cr
Paradeep Phosphates Management Change
Paradeep Phosphates Limited has appointed Mr. Raj Kumar Agrawal as an Additional Independent Director for a five-year term, effective October 13, 2026.
Paradeep Phosphates Other Announcement
Paradeep Phosphates filed its quarterly compliance certificate under Regulation 74(5) of SEBI regulations, as received from its Share Transfer Agent.
Other results update announcements
All →Wonderla Holidays Results Update
Wonderla reports best-ever Q2 with 42% income growth to ₹126 Cr and 90% EBITDA growth. H1 income up 41% to ₹378 Cr driven by new Chennai park.
UPL Results Update
UPL's Q2 FY27 revenue was ₹11,860 Cr with EBITDA of ₹2,312 Cr. H1 operational PATMI rose 33% YoY on sustained margin expansion.
Procter & Gamble Health Results Update
P&G Health's Q2 sales grew 18% to ₹376 crore and PAT rose 26% to ₹112 crore. Growth driven by brand strength and retail execution.
JTL Defence Results Update
JTL Defence reported H1 FY27 revenue of Rs.410 Cr, up 11.4x YoY, with EBITDA of Rs.47 Cr. Adjusted PAT of Rs.3 Cr was impacted by asset revaluation depreciation.
Mold-Tek Packaging Results Update
Mold-Tek reported Q2 FY27 net profit up 36% to Rs 21.06 Cr and H1 profit up 23% to Rs 46.67 Cr. Revenue and sales volumes also rose across both periods.
Epigral Results Update
Epigral reported Q2 FY27 PAT of ₹64 Cr, up 26% YoY, with revenue at ₹752 Cr. EBITDA margin was 18% despite elevated raw material costs.